Myoclonic seizure following intravenous verapamil injection: case report and review of the literature

An 18-month-old girl with supraventricular tachycardia was given a dose of intravenous verapamil and suffered a short myoclonic seizure which occurred again when she was given second and third doses. In the absence of any predisposing factors, direct drug reaction was implicated as the cause of the...

Full description

Saved in:
Bibliographic Details
Published inAnnals of tropical paediatrics Vol. 21; no. 3; pp. 271 - 272
Main Authors Maiteh, M., Daoud, A. S.
Format Journal Article
LanguageEnglish
Published Leeds Taylor & Francis 01.09.2001
Maney
Taylor & Francis Ltd
Subjects
Anti-Arrhythmia Agents - adverse effects
Anti-Arrhythmia Agents - therapeutic use
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Female
Humans
Infant
Injections, Intravenous
Medical sciences
Myoclonus - chemically induced
Pharmacology. Drug treatments
Tachycardia, Supraventricular - drug therapy
Toxicity: nervous system and muscle
Tropical medicine
Verapamil - adverse effects
Verapamil - therapeutic use
Jordan
Asia
Human
Nervous system diseases
Intravenous administration
Myoclonus
Toxicity
Epilepsy
Calcium antagonist
Infant
Antiarrhythmic agent
Cerebral disorder
Case study
Central nervous system disease
Aralkylamine
Verapamil
Online AccessGet full text

Cover

More Information
Summary:An 18-month-old girl with supraventricular tachycardia was given a dose of intravenous verapamil and suffered a short myoclonic seizure which occurred again when she was given second and third doses. In the absence of any predisposing factors, direct drug reaction was implicated as the cause of the seizure.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0272-4936
2046-9047
1465-3281
2046-9055
DOI:10.1080/02724930120077862